However, the association between serum CEA and peritoneal carcinomatosis is not well established in the literature, as evidenced by Shimada et al. in a systemic review of serum tumour markers in patients with metastatic gastric adenocarcinoma [7]. The gene discussed is CEACAM5; the disease is neoplasm.